CLEARMIND MEDICINE INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.5 USD | +2.04% |
|
+28.19% | -46.62% |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 1.78M 143M |
|---|---|---|---|---|---|
| Net income 2022 | -9M -719M | Net income 2023 | -8M -639M | EV / Sales 2022 | - |
| Net cash position 2022 | 388K 30.97M | Net cash position 2023 | 5.51M 440M | EV / Sales 2023 | - |
| P/E ratio 2022 |
-1.09
x | P/E ratio 2023 |
-0.09
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 100% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | +2.04% | ||
| 1 week | +28.19% | ||
| Current month | +26.29% | ||
| 1 month | +13.64% | ||
| 3 months | +3.45% | ||
| 6 months | -65.03% | ||
| Current year | -46.62% |
1 week
1.14
1.80
1 month
1.131.80
Current year
0.923.58
1 year
0.9223.70
3 years
0.92657.00
5 years
0.92657.00
10 years
0.92657.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/05/24 | 1.47 | -0.68% | 1,513,516 |
| 07/05/24 | 1.48 | +26.50% | 49,529,465 |
| 06/05/24 | 1.17 | -1.68% | 45,198 |
| 03/05/24 | 1.19 | +1.70% | 72,635 |
| 02/05/24 | 1.17 | -0.84% | 47,850 |
Delayed Quote Nasdaq, May 09, 2024 at 09:00 pm
More quotes
Clearmind Medicine Inc. is a psychedelic pharmaceutical biotech company. The Company is focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorders. The Company researches and develops psychedelic-based compounds and attempts to commercialize them as regulated medicines, foods, or supplements. The Companyâs intellectual portfolio consists of 15 patent families, including 27 granted patents and 24 pending applications. The portfolio spans a range of jurisdictions, including the United States, Europe, India, and China.
Calendar
25/06/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -46.62% | 4.79M | |
| +23.37% | 46.71B | |
| +48.83% | 41.8B | |
| -0.94% | 41.52B | |
| -5.86% | 29.55B | |
| +11.29% | 25.78B | |
| -20.92% | 19.26B | |
| +3.20% | 12.14B | |
| -2.67% | 12.08B | |
| +30.23% | 11.98B |
- Stock Market
- Equities
- CMND Stock
